Media Summary: The move is the latest in the ongoing weight-loss drug At a time when insulin makers are coming under increased pressure from patients and the government, The move follows criticism from federal lawmakers and advocacy groups. Check out more Eyewitness News -
Eli Lilly Cut The Cost - Detailed Analysis & Overview
The move is the latest in the ongoing weight-loss drug At a time when insulin makers are coming under increased pressure from patients and the government, The move follows criticism from federal lawmakers and advocacy groups. Check out more Eyewitness News -
